Invesco Ltd.

Position in STOK — Stoke Therapeutics, Inc.

CIK 914208 Atlanta, GA

Position in STOK

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$2,213,832

-$2,671,631 QoQ

Shares Held

67,660

-54.9% QoQ

Ownership

0.105%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#64

of 198 holders

Holding Since

Dec 2020

12 quarters on record

Voting authority Sole 0% Shared 98% None 2%

Healthcare · as of Jun 30, 2026

Invesco Ltd. holds $14,221,834,024 across 296 Biotechnology names. STOK ranks #112 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	8,043,052	$3,995,225,212
2	REGN	Regeneron Pharmaceuticals, Inc.	3,940,665	$2,457,162,245
3	ALNY	Alnylam Pharmaceuticals, Inc.	3,754,318	$1,130,162,341
4	INCY	Incyte Corp	4,080,461	$462,561,050
5	ARGX	Argenx SE	443,990	$411,920,598
6	AXSM	Axsome Therapeutics, Inc.	1,671,684	$409,178,086
7	MRNA	Moderna, Inc.	5,780,299	$404,794,337
8	LGND	Ligand Pharmaceuticals Inc	1,201,644	$379,827,645

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$2,213,832	67,660	-54.9%	Shares	Defined	2026-08-14
2026-03-31	$4,885,463	150,045	-42.2%	Shares	Defined	2026-05-12
2025-12-31	$8,237,892	259,543	+24.7%	Shares	Defined	2026-02-19
2025-09-30	$4,889,762	208,075	+417.5%	Shares	Defined	2025-11-13
2025-06-30	$456,348	40,207	+53.6%	Shares	Defined	2025-08-13
2025-03-31	$174,115	26,183	+117.0%	Shares	Defined	2025-05-12
2024-12-31	$133,075	12,065	-97.2%	Shares	Defined	2025-02-13
2024-06-30	$5,905,706	437,136	+232.0%	Shares	Defined	2024-08-13
2022-03-31	$2,771,736	131,674	+1312.1%	Shares	Defined	2022-05-16
2021-09-30	$237,227	9,325	+16.5%	Shares	Defined	2021-11-15
2021-06-30	$269,346	8,002	-68.4%	Shares	Defined	2021-08-17
2020-12-31	$1,568,624	25,329	—	Shares	Defined	2021-02-16
No filing history on record for this holder in this stock.